IMO this is an example of how cancer needs to be attacked. We need an army, not a pharmaceutical company. We need an army of biology lab workers that can do th

IMO this is an example of how cancer needs to be attacked. We need an army, not a pharmaceutical company. We need an army of biology lab workers that can do these bespoke attacks, perhaps enabled by software-generated compounds and formulae. I really don't want to say AI, but maybe even AI. Once we get the manual labor approach largely solved, then iterate on efficiencies. Immunotherapies seem to be "the answer". The issue is that they are a very complicated answer, to a complicated disease (cancer is actually thousands of genetic damage diseases under one moniker).